Fresenius Medical Care AG ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
3.7%projected annual EPS growth
Analyst Coverage
7analysts covering
FY EPS (est.)
$2.43next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release and Conference Call | 3 Nov 2026 |
| Q3 2026 Financial Report Publication | 6 Nov 2026 |
| Q4 and Full Year 2026 Earnings Release and Conference Call | 23 Feb 2027 |
Monitoring Framework
Key Performance Indicators
Global Quality Index Annually81.0Target: Continuous improvement of quality of care globally
Global Hospitalization Rate (days per patient) Annually1,060.0%Target: Reduction in length of hospital care per patient
Group Operating Income Margin (excluding special items) Quarterly1,130.0%Target: 10.5% to 12.0% for FY 2026; mid-teens percent by 2030
FME25+ Sustainable Savings (cumulative) Quarterly804MTarget: 1.2 billion EUR by 2027
Watch Items
- U.S. Dialysis Treatment Volumes and Growth TrendsTrigger: Negative organic volume growth or persistent weak treatment growth in U.S. clinicsAction: Evaluate contributing factors, optimize clinic utilization, and accelerate patient retention initiatives under the FME Reignite strategy.
- U.S. Rollout of the 5008X CAREsystemTrigger: Rollout delays or capital expenditures exceeding the planned 100 million to 150 million EUR investment phaseAction: Review supply chain logistics, adjust capital allocation priorities, and optimize manufacturing capacity in Care Enablement.
- Value-Based Care Risk Contracting and ProfitabilityTrigger: Operating margin falling back into negative territory (below 0.1% achieved in FY 2025)Action: Re-negotiate risk-sharing terms, optimize member month management, and refine clinical intervention protocols.
Research as of 2 Sep 2026